Research has shown that care provided through teledermatology is comparable to that delivered in face-to-face appointments, and future dermatologists are being taught to deliver care this way to improve patient access to expert dermatological care, said Nellie Konnikov, MD, professor and chief of dermatology at the Boston Department of Veterans Affairs.
Research has shown that care provided through teledermatology is comparable to that delivered in face-to-face appointments, and future dermatologists are being taught to deliver care this way to improve patient access to expert dermatological care, said Nellie Konnikov, MD, professor and chief of dermatology at the Boston Department of Veterans Affairs (VA).
Transcript (modified)
Is there any research on how the outcomes of teledermatology compare with those of face-to-face appointments?
Over the last 7 to 10 years, there are plenty of publications proving that it is effective methods of delivering dermatologic care ot our veterans. Research came from different VAs; for example, Milwaukee VA and Providence VA, especially, with satisfaction among patients and among doctors very high and comparable to care with face to face dermatology.
How would you like to see teledermatology evolve and improve?
Teledermatology is the part of the armamentarium within the whole healthcare delivery system. Right now we teach future dermatologists, residents in dermatology, to provide this type of care. And I think it will compliment any healthcare system in terms of access to expert dermatological care, and cost effectiveness of it.
What are some of the main barriers to implementing teledermatology?
The barrier could be the acceptance among primary care physicians because it's not how good the advice is, or how correct the diagnosis is, it's only if we have nurse practitioners, physicians assistants, or primary care physicians to follow our management advice, and to follow up with patients with skin disorders.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More